EXTRA-PHARMA
Board
1 director, no change since 2024Cavely BV
Director, permanent representative Carlijn VAN DEN EEDE
current term since 02-04-2024
listed in the 2025 annual accounts, filed on 29-09-2025
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 20-10-2020
Permanent representatives 1
Mandates through the years
4 names, the dashed line is todayCavely
Director
Director
VERLUCO
Director (not named in the articles)
Director (not named in the articles)
Véronique VAN ROEY
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- Cavely
- Director, since before 31-03-2024
- VERLUCO
- Director (not named in the articles), appointed by deed of 20-10-2020, until 01-04-2024
- Manager, until 20-10-2020
- Véronique VAN ROEY
- Director (not named in the articles), appointed by deed of 20-10-2020, until 01-04-2024
- Manager, until 20-10-2020
- VAN DEN EEDE Luc Roger Johan Theo
- Manager, until 20-10-2020
Control
100%
This company
EXTRA-PHARMA
Equity €559,094
Profit €97,780 in 2025
Further up the chainApolyne 100%
Capital
- Contribution
- €18,600
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- Cavely
- VERLUCO
Source: lists of holdings in the owners' accounts
Articles of association
deed of 20-10-2020 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Wednesday of August at 20:00